Evolution of arterial redox potential during CPB. حسب Vincent Pey (21433304)

الموضوعات:

Cohort characteristics. حسب Vincent Pey (21433304)

الموضوعات:

Descriptive table of circulatory variables during CPB. حسب Vincent Pey (21433304)

الموضوعات:

Glucose/galactose with extended interferon-priming does not impact levels of ISG RNAs or non-ISG proteins levels. حسب Tyron Chang (9922533)

Potato gene ontology enrichment results significant at <i>p</i> < 0.01. حسب Margaret A. Carpenter (6104180)

Genome-wide significant SNPs for meat L*15 min and a*15 min. حسب Jiahong Sun (6497603)

Statistically Significant Results for Heart Rate Variability (HRV) Indices for High and Low Authority Groups. حسب David Vagni (8060432)

الموضوعات:

Statistically Significant Results for Heart Rate Variability (HRV) Indices for High and Low Clarity Groups. حسب David Vagni (8060432)

الموضوعات:

Identification of ACADM, ANGPTL4, and NFKB2 as significant predictors of OS in the TCGA-KIRC cohort. حسب Yu Zhang (12946)

الموضوعات:

Distinct and shared gene expression patterns among leukemia cell lines following EF-24 treatment. حسب Ajeet P. Singh (22298432)

الموضوعات:

EF-24 treatment induces distinct gene expression changes in Kasumi-1 cells. حسب Ajeet P. Singh (22298432)

الموضوعات:

EF-24 treatment alters gene expression profiles in HL-60 cells. حسب Ajeet P. Singh (22298432)

الموضوعات:

Expression analysis of downstream target genes in the IL-10 signaling pathway across myeloid leukemia cell lines. حسب Ajeet P. Singh (22298432)

الموضوعات:

EF-24 treatment modulates gene expression in THP-1 cells. حسب Ajeet P. Singh (22298432)

الموضوعات:

Expression analysis of downstream target genes in the p38/MAPK signaling pathway across myeloid leukemia cell lines. حسب Ajeet P. Singh (22298432)

الموضوعات:

EF-24 treatment disrupts key molecular pathways associated with cell survival, proliferation, and viability. حسب Ajeet P. Singh (22298432)

الموضوعات:

Segmented regression analysis of time to intravenous antimicrobial administration (IVA) at intervention and control sites during the implementation period. حسب J Mark Ansermino (13958512)

الموضوعات:

Interrupted time series analysis showing time to intravenous antimicrobials (IVA) in minutes at intervention and control sites in Uganda during baseline and implementation periods. حسب J Mark Ansermino (13958512)

الموضوعات:

Kenya: Enrolment, time to IVA, mortality, admissions and readmissions at sites in Kenya. حسب J Mark Ansermino (13958512)

الموضوعات:

Uganda: enrolment, time to IVA, mortality, admissions and readmissions. حسب J Mark Ansermino (13958512)

الموضوعات: